News

The decision comes following reports of 16,000 cases across 75 countries and territories around the world.

ICYMI, this week we had stories about skin cancer, FDA approvals, vitiligo, consumer trends, and more.

Click to see a preview of what to expect this week.

ICYMI, this week we had stories about atopic dermatitis, acne, psoriasis, consumer trends, and more.

Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.

The groundbreaking approval of sirolimus topical gel brings relief to patients with facial angiofibroma related to tuberous sclerosis complex with the first FDA-approved topical treatment.

The increases had no impact on the efficacy of the drug and were rarely associated with symptoms or sequelae.

ICYMI, this week we had stories about the Society for Pediatric Dermatology 2022 Meeting, FDA updates, mental health, and more.

Verrica is complying with the FDA through 3 Complete Response Letters to achieve the first FDA-approved treatment of molluscum contagiosum.

This week's edition of the Mainstream Patient features stories about abortions, spray sunscreen, tinted moisturizers, and more.

ICYMI, this week we had stories about pediatric atopic dermatitis, managing complex diseases, Medicare, and more.

This week's edition of the Mainstream Patients features stories about FDA's latest approval, abortion, and more.

Click to see a preview of what to expect this week.

In this video interview, Jean Bolognia, MD, discusses her recent presentation at the 2022 Society of Dermatology Physician Assistants Annual Summer Meeting regarding how to identify the various cutaneous manifestations of lupus.

The Society for Dermatology Physician Assistants (SDPA) begins its summer dermatology conference today, which will continue until Sunday, June 19, 2022, in Austin, Texas. Follow along for coverage.

This week's edition of the Mainstream Patients features stories about skin care for trans women, Aztec clay for the skin, and more.

ICYMI, this week we had stories from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, FDA's approval of dupilumab, and more.

Click here to answer this week's poll.

ICYMI, this week we had stories from the trending skin care from May, FDA's newest pipeline move, and more.

This week's edition of the Mainstream Patients features stories about heat rash, drinking Aloe Vera juice, and more.

In this month’s “Meet the Aesthetic Expert” column, Will Kirby, DO, FAOCD, talks with Ryan Greene, MD, PhD, FACS, about how this board-certified facial plastic surgeon applies his expertise to non-surgical aesthetics and what that means for improving outcomes with injectables and other minimally invasive techniques.

Click here to answer this week's poll.

ICYMI, this week we had stories from the about precision medicine, FDA's newest approval, and more.

Study finds financial, cultural barriers to care common among rural residents.

Medical staff, pushed past their breaking point, say something has to change.

In this week’s Pointers with Dr Portela, the 208SkinDoc dives into the reason why his channel exists and how he plans to help the average patient watching his YouTube videos.

AMA, Joint Commission aim to improve outcomes for marginalized patients

This week's edition of the Mainstream Patients features stories about the top 10 best acne-fighting ingredients and medications in 2022, Bill Nye talks not using oil on the scalp, and more.

Verbal abuse, discrimination towards doctors is common, study finds

ICYMI, this week we had stories from the 2022 American College of Mohs Surgery Annual Meeting, bimekizumab's FDA set back, and more.